FDA product code QCX: Retrograde Intubation Set

QCX is the FDA product code for retrograde intubation set. It is a Class II device, regulated under 21 CFR 868.5095 and reviewed by the Anesthesiology panel. Devices under QCX reach the market by 510(k); FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.

Definition

A retrograde intubation device is a prescription device used to perform retrograde intubation via the cricothyroid membrane. The device may contain or be labeled for use with guidewires and intubating catheters, in addition to needles (21 CFR 8685090), syringe (21 CFR 880.5860), and hemostats (21 CFR 878.4800).

Classification

FieldValue
Device nameRetrograde Intubation Set
Device classClass II
Regulation21 CFR 868.5095
Review panelAN — Anesthesiology
Medical specialtyAnesthesiology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Recalls for QCX devices

FDA recall records list no recalls for product code QCX.

Frequently asked questions

What is FDA product code QCX?

QCX is the FDA product code for retrograde intubation set. It is a Class II device, regulated under 21 CFR 868.5095 and reviewed by the Anesthesiology panel.

What device class is QCX?

Class II, regulation 21 CFR 868.5095. Typical premarket route: 510(k).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Anesthesiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times